In breast cancer, ERO1α enhances the expression of PD-L1 by facilitating oxidative protein folding and augmentation of HIF1α; conversely, depleting ERO1-α inhibited apoptosis of PD-1+ T cells (Tanaka et al., 2017). The gene discussed is ERO1A; the disease is breast carcinoma.